SOPHiA GENETICS Publicly Traded Corporation
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
Investors
Connections from
Total Funding:
265152150
Founded Date:
2011-01-01
Employee Number:
251-500
Last Funding Date:
2024-05-02
Headquarters:
Boston,Massachusetts,United States,North America
Funding Stage:
IPO
Funding Total Value:
265152150
Last Funding Total Usd:
15000000
Last Funding Total Currency:
USD
Last Funding Total Value:
15000000
Founders:
Jurgi Camblong,Lars Steinmetz,Pierre Hutter
Phone Number:
+1 617 982 1210
Stock Symbol:
SOPH
City:
Boston
Region:
Massachusetts
Country:
United States








.png)

.png)













